The U.S. CDC Director Rochelle P. Walensky, M.D., M.P.H., announced her endorsement of the Advisory Committee on Immunization Practices (ACIP) recommendation that Novavax's COVID-19 Vaccine, Adjuvanted, become available as a primary two-dose series option for most adults.
Novavax's protein-based COVID-19 vaccine will be available in the USA soon. To date, the U.S. government has agreed to order 3.2 million doses of the Novavax vaccine under these existing agreements.
U.S. CDC Endorses Protein-Based COVID-19 Vaccine
Yellow Fever Vaccine Coadministration Confirmed Safe for International Travelers
For international travelers to optimize an immune response from pre-departure vaccination, multiple factors such as the type of vaccine should be considered.
Another factor is the coadministration of multiple vaccines during a single appointment.
According to the U.S. CDC, most vaccines can be divided into two general categories: live or non-live.
CDC Stops Tracking COVID-19 Cases on Cruise Ships
Decision allows cruise lines to set their own COVID-19 policies
CDC Backs COVID-19 Vaccine From Novavax
Vaccine uses nanoparticles made of proteins from the surface of the coronavirus to stimulate an immune response
Risks for Diabetes, CVD Up in Acute, Postacute COVID-19 Phases
However, from 13 to 52 weeks after COVID-19, no increase was seen for diabetes mellitus, cardiovascular disease
Increased Blood Viscosity Linked to Mortality in COVID-19
Hospitalized COVID-19 patients with increased estimated blood viscosity may have greater risk for in-hospital mortality